HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Substance P modulates colitis-associated fibrosis.

Abstract
Substance P (SP) and the neurokinin-1 receptor (NK-1R) are involved in the development of colitis and mucosal healing after colonic inflammation. We studied whether SP modulates colonic fibrosis by using a chronic model of trinitrobenzenesulfonic acid (TNBS)-induced colitis in wild-type (WT) and NK-1R-deficient (NK-1R KD) mice. We found increased mRNA expression levels of collagen, vimentin, and the fibrogenic factors transforming growth factor β1 and insulin-like growth factor 1 in the chronically inflamed colons of WT mice treated with repeated intracolonic TNBS administrations. Fibrosis in TNBS-treated mice was also evident immunohistochemically by collagen deposition in the colon. Treatment of TNBS-exposed WT mice with the NK-1R antagonist CJ-12255 reduced colonic inflammation, colonic fibrosis, fibroblast accumulation, and expression levels of the fibrogenic factors. NK-1R knockout mice chronically exposed to TNBS had similar colonic inflammation compared with WT, but reduced colonic fibrosis, fibroblast accumulation, and expression levels of fibrogenic factors. Immunohistochemical staining also showed co-localization of NK-1R with fibroblasts in inflamed colons of mice and in colonic mucosa of patients with Crohn's disease. Exposure of human colonic CCD-18Co fibroblasts to SP (10 nmol/L) increased cell migration. SP stimulated collagen synthesis in CCD-18Co fibroblasts in the presence of transforming growth factor β1 and insulin-like growth factor 1, and this effect was reduced by Akt inhibition. Thus, SP, via NK-1R, promotes intestinal fibrogenesis after chronic colitis by stimulating fibrotic responses in fibroblasts.
AuthorsHon Wai Koon, David Shih, Iordanes Karagiannides, Dezheng Zhao, Zafeer Fazelbhoy, Tressia Hing, Hua Xu, Bao Lu, Norma Gerard, Charalabos Pothoulakis
JournalThe American journal of pathology (Am J Pathol) Vol. 177 Issue 5 Pg. 2300-9 (Nov 2010) ISSN: 1525-2191 [Electronic] United States
PMID20889569 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • 6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid
  • Bridged Bicyclo Compounds, Heterocyclic
  • Neurokinin-1 Receptor Antagonists
  • Receptors, Neurokinin-1
  • Transforming Growth Factor beta1
  • Vimentin
  • Substance P
  • Insulin-Like Growth Factor I
  • Trinitrobenzenesulfonic Acid
  • Collagen
  • Proto-Oncogene Proteins c-akt
Topics
  • Animals
  • Bridged Bicyclo Compounds, Heterocyclic (metabolism)
  • Cell Line
  • Cell Movement (drug effects)
  • Colitis (chemically induced, metabolism, pathology)
  • Collagen (metabolism)
  • Colon (cytology, metabolism, pathology)
  • Fibroblasts (cytology, drug effects, metabolism, pathology)
  • Fibrosis
  • Humans
  • Insulin-Like Growth Factor I (metabolism)
  • Intestinal Mucosa (cytology, metabolism, pathology)
  • Mice
  • Mice, Knockout
  • Neurokinin-1 Receptor Antagonists
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Receptors, Neurokinin-1 (genetics, metabolism)
  • Substance P (pharmacology)
  • Transforming Growth Factor beta1 (metabolism)
  • Trinitrobenzenesulfonic Acid (pharmacology)
  • Vimentin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: